Signe Schmidt

1.9k total citations
76 papers, 1.3k citations indexed

About

Signe Schmidt is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Signe Schmidt has authored 76 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Endocrinology, Diabetes and Metabolism, 48 papers in Surgery and 39 papers in Genetics. Recurrent topics in Signe Schmidt's work include Diabetes Management and Research (71 papers), Pancreatic function and diabetes (48 papers) and Diabetes and associated disorders (38 papers). Signe Schmidt is often cited by papers focused on Diabetes Management and Research (71 papers), Pancreatic function and diabetes (48 papers) and Diabetes and associated disorders (38 papers). Signe Schmidt collaborates with scholars based in Denmark, United Kingdom and Slovakia. Signe Schmidt's co-authors include Kirsten Nørgaard, Ajenthen G. Ranjan, Sten Madsbad, John Bagterp Jørgensen, Henrik Madsen, Jens J. Holst, Anne Katrine Duun‐Henriksen, Niels Kjølstad Poulsen, Dimitri Boiroux and Isabelle Isa Kristin Steineck and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

Signe Schmidt

75 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Signe Schmidt Denmark 19 1.2k 663 541 226 80 76 1.3k
Ahmad Haidar Canada 27 2.0k 1.7× 1.6k 2.4× 1.1k 2.0× 87 0.4× 108 1.4× 71 2.2k
Kavita Kumareswaran United Kingdom 20 1.2k 1.0× 905 1.4× 701 1.3× 89 0.4× 42 0.5× 32 1.3k
Monika Reddy United Kingdom 23 1.1k 1.0× 713 1.1× 655 1.2× 45 0.2× 68 0.8× 66 1.4k
Firas H. El-Khatib United States 18 1.6k 1.4× 1.3k 2.0× 921 1.7× 50 0.2× 94 1.2× 30 1.8k
Paolo Rossetti Spain 24 1.1k 1.0× 787 1.2× 435 0.8× 57 0.3× 136 1.7× 54 1.3k
Mary C. Oliveri United States 12 611 0.5× 454 0.7× 364 0.7× 332 1.5× 51 0.6× 18 1.1k
J. Dziura United States 3 397 0.3× 366 0.6× 250 0.5× 157 0.7× 32 0.4× 9 680
Alicia Schiffrin Canada 21 970 0.8× 372 0.6× 421 0.8× 146 0.6× 109 1.4× 45 1.3k
Peter Calhoun United States 24 1.5k 1.3× 1.0k 1.5× 949 1.8× 65 0.3× 34 0.4× 90 1.7k
Manasi Sinha United States 7 664 0.6× 646 1.0× 405 0.7× 43 0.2× 57 0.7× 7 917

Countries citing papers authored by Signe Schmidt

Since Specialization
Citations

This map shows the geographic impact of Signe Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Signe Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Signe Schmidt more than expected).

Fields of papers citing papers by Signe Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Signe Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Signe Schmidt. The network helps show where Signe Schmidt may publish in the future.

Co-authorship network of co-authors of Signe Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Signe Schmidt. A scholar is included among the top collaborators of Signe Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Signe Schmidt. Signe Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Christensen, Merete Bechmann, Bolette Hartmann, Jens J. Holst, et al.. (2024). Metabolic and Hormonal Responses to Isomaltulose Ingestion Before or During Sustained Submaximal Exercise in Adults with Type 1 Diabetes Using Automated Insulin Delivery Systems. Nutrients. 16(23). 4098–4098. 1 indexed citations
2.
Heebøll, Sara, Marie Winther‐Sørensen, Sasha A. S. Kjeldsen, et al.. (2024). Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms. Metabolism. 156. 155915–155915. 7 indexed citations
3.
Holmager, Pernille, et al.. (2024). GLP-1 Receptor Agonists in Overweight and Obese Individuals With Type 1 Diabetes Using an Automated Insulin Delivery Device: A Real-World Study. Journal of Diabetes Science and Technology. 19(2). 286–291. 2 indexed citations
4.
Cleal, Bryan, Lene Eide Joensen, Kirsten Nørgaard, et al.. (2024). Associations between use of diabetes technology and diabetes distress: a Danish cross-sectional survey of adults with type 1 diabetes. BMJ Open. 14(3). e080053–e080053. 3 indexed citations
5.
Schmidt, Signe, et al.. (2023). Automated Insulin Delivery Around Exercise in Adults with Type 1 Diabetes: A Pilot Randomized Controlled Study. Diabetes Technology & Therapeutics. 25(7). 476–484. 9 indexed citations
6.
Schmidt, Signe, et al.. (2023). Glycemia Around Exercise in Adults with Type 1 Diabetes Using Automated and Nonautomated Insulin Delivery Pumps: A Switch Pilot Trial. Diabetes Technology & Therapeutics. 25(4). 287–292. 9 indexed citations
7.
Ranjan, Ajenthen G., et al.. (2023). Effects of a Low-Carbohydrate-High-Protein Pre-Exercise Meal in Type 1 Diabetes—a Randomized Crossover Trial. The Journal of Clinical Endocrinology & Metabolism. 109(1). 208–216. 5 indexed citations
8.
Kelly, Aaron S., Silva Arslanian, Dan Hesse, et al.. (2023). Reducing BMI below the obesity threshold in adolescents treated with once‐weekly subcutaneous semaglutide 2.4 mg. Obesity. 31(8). 2139–2149. 24 indexed citations
9.
Andersen, Henrik U., et al.. (2023). Associations between insulin pump self‐management and HbA1c in type 1 diabetes. Diabetic Medicine. 40(6). e15068–e15068. 5 indexed citations
10.
Schmidt, Signe, Ulrik Pedersen‐Bjergaard, E. Hommel, et al.. (2023). Associations between clinical and psychosocial factors and HbA1c in adult insulin pump users with type 1 diabetes. Acta Diabetologica. 60(8). 1089–1097. 3 indexed citations
11.
Schmidt, Signe, et al.. (2022). Metabolic and physiological responses to graded exercise testing in individuals with type 1 diabetes using insulin pump therapy. Diabetes Obesity and Metabolism. 25(3). 878–888. 3 indexed citations
12.
Knudsen, Torben, et al.. (2021). Parameter Estimation for a Jump Diffusion Model of Type 2 Diabetic Patients in the Presence of Unannounced Meals. VBN Forskningsportal (Aalborg Universitet). 2 indexed citations
13.
Al‐Sari, Naba, Signe Schmidt, Tommi Suvitaival, et al.. (2021). Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post‐hoc analysis of a randomized crossover trial. Endocrinology Diabetes & Metabolism. 4(2). e00213–e00213. 16 indexed citations
14.
Andersen, Henrik U., Bryan Cleal, Mette Andersen Nexø, et al.. (2021). Insulin Pump Treatment in Adults with Type 1 Diabetes in the Capital Region of Denmark: Design and Cohort Characteristics of the Steno Tech Survey. Diabetes Therapy. 13(1). 113–129. 9 indexed citations
15.
Schmidt, Signe, Mette Andersen Nexø, Ole Nørgaard, et al.. (2020). Psychosocial factors associated with HbA1c in adults with insulin pump‐treated type 1 diabetes: a systematic review. Diabetic Medicine. 37(9). 1454–1462. 9 indexed citations
16.
Schmidt, Signe, E. Hommel, Hans Perrild, et al.. (2020). Efficacy of Bolus Calculation and Advanced Carbohydrate Counting in Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Technology & Therapeutics. 23(2). 95–103. 12 indexed citations
17.
Schmidt, Signe, et al.. (2019). Glucose Sensor Accuracy After Subcutaneous Glucagon Injections Near to Sensor Site. Diabetes Technology & Therapeutics. 22(2). 131–135. 1 indexed citations
18.
Steineck, Isabelle Isa Kristin, Ajenthen G. Ranjan, Signe Schmidt, et al.. (2019). Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study. Diabetologia. 62(4). 582–592. 19 indexed citations
19.
Schmidt, Signe, et al.. (2012). Use of an Automated Bolus Calculator in MDI-Treated Type 1 Diabetes. Diabetes Care. 35(5). 984–990. 87 indexed citations
20.
Schmidt, Signe & Kirsten Nørgaard. (2012). Sensor-Augmented Pump Therapy at 36 Months. Diabetes Technology & Therapeutics. 14(12). 1174–1177. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmad Haidar Breakdown of academic impact, for papers by Kavita Kumareswaran Breakdown of academic impact, for papers by Monika Reddy Breakdown of academic impact, for papers by Firas H. El-Khatib Breakdown of academic impact, for papers by Paolo Rossetti Breakdown of academic impact, for papers by Mary C. Oliveri Breakdown of academic impact, for papers by J. Dziura Breakdown of academic impact, for papers by Alicia Schiffrin Breakdown of academic impact, for papers by Peter Calhoun Breakdown of academic impact, for papers by Manasi Sinha
Rankless by CCL
2026